Malignant Hyperthermia: Difference between revisions
No edit summary Tags: Mobile edit Mobile web edit Advanced mobile edit |
No edit summary |
||
| Line 10: | Line 10: | ||
__NOTOC__ __NOEDITSECTION__ | __NOTOC__ __NOEDITSECTION__ | ||
https://link.springer.com/chapter/10.1007/978-4-431-68346-9_1 | [https://link.springer.com/chapter/10.1007/978-4-431-68346-9_1 History of Malignant Hyperthermia] | ||
See also http://www.mhaus.org | See also [http://www.mhaus.org Malignant Hypertgermia Association of the United States] | ||
[https://doi.org/10.1111/anae.15317 Malignant hyperthermia 2020 Guideline from the Association of Anaesthetists] | |||
https://doi.org/10.1111/anae.15317 | |||
http://malignanthyperthermia.org.au/resource-kit/ | http://malignanthyperthermia.org.au/resource-kit/ | ||
Revision as of 17:34, 23 May 2023
This is a Stub Notice. This page has not been completed. You can work on this page by signing in and going to the Edit tab. Thanks for helping to make PedsAnesthesia.Net Wiki useful.
Go to the Main Page to see the Topic Outline.
Go to the Generalized Suggested Outline for information on case-specific details for each page.
Go to the Test Page for examples on how to use references in the page.
History of Malignant Hyperthermia
See also Malignant Hypertgermia Association of the United States
Malignant hyperthermia 2020 Guideline from the Association of Anaesthetists
http://malignanthyperthermia.org.au/resource-kit/
https://twitter.com/hypoxicchicken/status/1232963055467712514?s=21
Indications for Malignant Hyperthermia Susceptibility Diagnostics in Patients without Adverse Anesthetic Events in the Era of Next-generation Sequencing. Anesthesiology. 2022 Jun 1;136(6):940-953. PMID: 35285867